Novavax, the protein-based coronavirus vaccine produced by the US company of the same name, will begin offering its inoculations to the people of Greece in early March, according to greekreporter.com.
The Gaithersburg, Maryland-based pharmaceuticals firm, which earned emergency authorization for its vaccine in the EU on December 20, received the go-ahead from UK drug regulatory authorities in the UK today.
The President and Chief Executive Officer at Novavax, Stanley C. Erck, welcomed the EU’s decision, thanking the EMA for their thorough assessment.
RELATED TOPICS: Greece, Greek tourism news, Tourism in Greece, Greek islands, Hotels in Greece, Travel to Greece, Greek destinations, Greek travel market, Greek tourism statistics, Greek tourism report
Photo Source: pixabay.com
